Cyclana Bio has been granted Health Research Authority (HRA) and Research Ethics Committee (REC) approval by the NHS to launch a study into endometriosis.  The biotechnology company will now go ahead with its 500-patient clinical observational study, being called PEMP (Predicting Endometriosis Mechanisms and Populations), to improve understanding of the disease physiology of endometriosis.  Figures show […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!